---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-050659"
form_type: "8-K"
ticker: "ABSI"
cik: "0001672688"
company_name: "Absci Corp"
filed_at: "2024-02-28T23:59:59+00:00"
generated_at: "2026-06-05T09:03:18.231053+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Absci prices $75.2M public offering of 16.7M shares at $4.50; net proceeds $70.2M

## Summary
- Offering of 16.7M shares at $4.50/share; gross proceeds ~$75.2M; net proceeds ~$70.2M.
- Underwriters granted 30-day option to purchase up to 2.505M additional shares.
- Net proceeds to fund internal asset programs, Integrated Drug Creation platform, AI/wet-lab tech, and working capital.
- Cash runway extended into first half of 2027; offering expected to close March 1, 2024.
- Joint book-running managers: Morgan Stanley and TD Cowen.

## SEC filing metadata
- accession: 0001193125-24-050659
- form_type: 8-K
- ticker: ABSI
- cik: 0001672688
- company_name: Absci Corp
- filed_at: 2024-02-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672688/000119312524050659/0001193125-24-050659-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672688/000119312524050659/d768554d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-050659
- JSON: https://secwatch.observer/filing/0001193125-24-050659.json
- Plain text: https://secwatch.observer/filing/0001193125-24-050659.txt

## Key facts
- Material Agreements
  Absci Corp entered into Underwriting Agreement with Morgan Stanley & Co. LLC and Cowen & Company, LLC valued at public offering price of $4.50 per share (effective 2024-02-27).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Morgan Stanley & Co. LLC and Cowen & Company, LLC
  - Value: public offering price of $4.50 per share
  - Effective: 2024-02-27
  source text: On February 27, 2024, Absci Corporation (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Morgan Stanley & Co. LLC and Cowen & Company, LLC (the “ Underwriters ”), relating to the issuance and sale of an aggregate of 16,700,000 shares (the “ Underwritten Shares ”) of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1672688/000119312524050659/0001193125-24-050659-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.